18 May 2013
Keywords: cortech, starts, phase, ii, study, started, its
Article | 01 March 1993
- Cortech has started a Phase II study of its bradykinin antagonist,
Bradycor, in patents with system inflammatory response syndrome and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com